Loading...
NPI 1346254620 · Omaha, NE · Durable Medical Equipment & Medical Supplies
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Diabetes Supply Center Of The Midlands LLC is a durable medical equipment & medical supplies provider located in Omaha, Nebraska. This profile covers 0 Medicare and 19 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Diabetes Supply Center Of The Midlands LLC |
| Address | 10304 Crown Point Ave |
| City | Omaha |
| State | NE |
| ZIP | 68134 |
| Taxonomy | Durable Medical Equipment & Medical Supplies |
| NPI Enumerated | July 29, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $40.7M |
| Medicare | $0 |
This provider has no Medicare billing on file and reports $40.7M in lifetime Medicaid revenue, making its observable business effectively single-payer (Medicaid)-focused in the available data. Analysts should treat Medicaid as the primary revenue source for evaluation and benchmarking.
Revenue is highly concentrated in a small set of diabetes-related supply codes: the precomputed top three Medicaid codes (A9276, A9274, A4239) account for 64.8% of the provider's total Medicaid revenue. The individual contributions are substantial: A9276 $14.4M (35.5%), A9274 $6.8M (16.7%), and A4239 $5.1M (12.6%), indicating concentration risk around a few product lines.
Code mix and descriptions show the operation is primarily a diabetes durable medical equipment and supplies supplier focused on continuous glucose monitoring (CGM) and insulin-delivery ecosystems. High-revenue codes include CGM sensors (A9276), transmitters (A9277), receivers (A9278), supply allowances for CGM (A4239, K0553), and disposable external ambulatory insulin delivery systems (A9274), which together imply the provider supplies sensors, transmitters, receivers, recurring monthly supplies, infusion sets (A4230/A4231), and some pumps (E0784).
The provider appears to be the sole reported in-state Medicaid biller for multiple high-revenue CGM and pump-related codes: it ranks #1 of 1 providers in-state for A9276, A9274, A9277, K0553 and several other codes, often with the dataset note "0th percentile; no state peer volume comparison available." This pattern indicates local dominance for those specific billed items but also limits peer benchmarking because there are no other in-state reporters to compare against.
There are nuances in competitive standing where peer comparisons exist: A4239 ranks #1 of 2 providers in-state (100th percentile) but is labeled "typical, unremarkable volume," and A4222 ranks #2 of 6 providers in-state (80th percentile) also described as "typical, unremarkable volume." These notes signal that being top-ranked does not necessarily mean exceptional volume versus expected norms for those codes.
Because many of the largest-revenue codes are sole in-state reporters (the dataset shows multiple codes with "no state peer volume comparison available"), payers should be cautious when using state peer percentiles to infer market share or over/underperformance; several top lines cannot be benchmarked within Nebraska. Analysts should rely on absolute Medicaid dollar volumes and the provided rank labels rather than percentile-based comparisons for those items.
The entity has a long NPI tenure, enumerated 2006-07-29 (~20 years ago), consistent with an established supplier relationship with Medicaid programs and sufficient time to build recurring supply streams for chronic diabetes management. Tenure supports the interpretation that the current billing patterns reflect an ongoing, stable operational focus rather than a short-term activity spike.
From a payer-management perspective, the combination of concentrated revenue in CGM/sensor and insulin-delivery supplies and frequent sole-provider status for many codes suggests potential operational leverage in contract negotiations and prior-authorization strategies. Given the $40.7M Medicaid footprint and concentration in a few codes (64.8% from the top three), payers should evaluate reimbursement arrangements, stocking/fulfillment dependencies, and continuity-of-supply contingencies for the specific codes driving most spend.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
19 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | 41,130 | $350 | $14.4M |
| A9274 | External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories | 10,710 | $640 | $6.8M |
| A4239 | Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 31,000 | $170 | $5.1M |
| A9277 | Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 8,730 | $420 | $3.7M |
| K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 20,390 | $140 | $2.9M |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | 6,840 | $380 | $2.6M |
| A4230 | Infusion set for external insulin pump, non needle cannula type | 13,700 | $170 | $2.4M |
| E0784 | External ambulatory infusion pump, insulin | 510 | $1,780 | $912.6K |
| A4232 | Syringe with needle for external insulin pump, sterile, 3 cc | 13,520 | $50 | $716.3K |
| A9278 | Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 1,700 | $400 | $679.7K |
Showing 1–10 of 19
How this provider's Medicaid billing volume and revenue compare to other Nebraska providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Nebraska median
19 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | 1 | 10 | 41,130 | $350 | $14.4M |
| A9274 | External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories | 1 | 10 | 10,710 | $640 | $6.8M |
| A9277 | Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 1 | 10 | 8,730 | $420 | $3.7M |
| K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 1 | 10 | 20,390 | $140 | $2.9M |
| A4239 | Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 1 | 10 | 15,680 | $170 | $2.6M |
| A4230 | Infusion set for external insulin pump, non needle cannula type | 1 | 10 | 13,700 | $170 | $2.4M |
| E0784 | External ambulatory infusion pump, insulin | 1 | 10 | 510 | $1,780 | $912.4K |
| A4232 | Syringe with needle for external insulin pump, sterile, 3 cc | 1 | 10 | 13,520 | $50 | $715.5K |
| A9278 | Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 1 | 10 | 1,700 | $400 | $679.8K |
| A4222 | Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) | 2 | 10 | 630 | $220 | $557.2K |
Showing 1–10 of 19
Other providers in the same ZIP code as Diabetes Supply Center Of The Midlands LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.